Two Sigma Securities
PVCT

Two Sigma Securities’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Two Sigma Securities’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,466
Closed -$4K – 871
2016
Q2 		$4K Sell
11,466
-10,345
-47% -$3.94K ﹤0.01% 414
2016
Q1 		$8K Buy
+21,811
New +$8.98K 0.01% 269
2015
Q1 		– Sell
-12,490
Closed -$10K – 371
2014
Q4 		$10K Buy
+12,490
New +$11.4K 0.01% 241

Other funds holding PVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Two Sigma Securities's PVCT Position: Q3 2016 in Review

Two Sigma Securities sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q3 2016, closing a stake of 11,466 shares — an estimated $4K sold.

Two Sigma Securities first reported a position in PVCT in Q4 2014 and held it in 3 quarters. The position peaked at $10K in Q4 2014. 41 funds tracked by Wall St. Rank hold PVCT as of Q3 2016.

  • Two Sigma Securities reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q3 2016 after selling out during the quarter.
  • Two Sigma Securities sold 11,466 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q3 2016, an estimated $4K.
  • Two Sigma Securities first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and held it in 3 quarters.
  • Two Sigma Securities's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $10K in Q4 2014.
  • 41 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q3 2016.

Based on Two Sigma Securities's 13F filing for Q3 2016, filed 14 Nov 2016.